NBY- Novabay Pharmaceuticals, Inc.

Name: Novabay Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Novabay Pharmaceuticals, Inc. (NBY) has 4 insiders with recent SEC Form 4 filings, including 8 buys and 4 sells. NBY is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	R01 Fund LP	56.81M	$110.77M	-
10%	Framework Ventures IV L.P.	56.81M	$110.77M	-
10%	Lazar David E.	6.39M	$12.46M	-
CEO	Kazley Michael John	4.12M	$8.03M	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 1, 2021	Kunin Audrey	Chief Product Officer	Buy	14,848	$0.49	$7,275.52	+12.3%	-41.8%	-88.3%
Dec 1, 2021	Kunin Jeffrey	President, Dermadoctor, LLC	Buy	14,848	$0.49	$7,275.52	+12.3%	-41.8%	-88.3%
Nov 30, 2021	Kunin Jeffrey	President, Dermadoctor, LLC	Buy	30,000	$0.46	$13,800.00	+32.9%	-36.8%	-87.9%
Nov 30, 2021	Kunin Audrey	Chief Product Officer	Buy	30,000	$0.46	$13,800.00	+32.9%	-36.8%	-87.9%
Nov 23, 2021	Kunin Audrey	Chief Product Officer	Buy	91,133	$0.46	$41,868.27	+364.5%	-38.4%	-84.5%
Nov 23, 2021	Kunin Jeffrey	President, Dermadoctor, LLC	Buy	91,133	$0.46	$41,868.27	+364.5%	-38.4%	-84.5%
Aug 17, 2020	Wu Mijia	Director	Sell	20,000	$1.35	$27,000.00	-100%	-	-
Aug 1, 2020	Fu Jian Ping	10% Owner	Sell	1,302,350	$1.23	$1,601,890.50	-24.6%	-	-
Jun 11, 2019	Fu Jian Ping	10% Owner	Sell	380,954	$3.84	$1,462,863.36	-6.7%	-	-
Jun 11, 2019	Pioneer Pharma (hong Kong) Co Ltd	10% Owner	Sell	24,326	$4.04	$98,277.04	-0.5%	-	-

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC